A two-day United Nations High-Level Meeting (HLM) on HIV and AIDS has been concluded on a high note in New York. Majority of Member States have adopted a new Political Declaration on HIV and AIDS with strong support. The declaration reaffirms global commitment to ending AIDS as a public health threat by 2030 and sets...
Category: Global News
Post
MALAWI ATTENDS UN HIGH-LEVEL MEETING ON HIV AND AIDS IN NEW YORK
Malawi is participating in the 2026 United Nations High-Level Meeting on HIV and AIDS currently taking place in New York from June 22 to 23 2026. During the conference, world leaders, policymakers and partners are expected to adopt a new Political Declaration aimed at accelerating efforts to end AIDS as a public health threat by...
Post
African Experts and Global Partners Launch The Lancet HIV & The Lancet Global Health Joint Series on Sustainable HIV Prevention in Africa, Calling for a New Era in HIV Response
December 2, 2025 A new, groundbreaking six-paper series from The Lancet HIV and The Lancet Global Health journals, co-authored by more than two dozen African and global experts, outlines a roadmap for sustainable, nationally led HIV prevention across the continent. December 3, 2025 — At the 2025 International Conference on AIDS and Sexually Transmitted Infections in Africa (ICASA), Malawi’s...
Post
From Relief to Resilience! NAC Advocates for Sustainable, African-Focused Health Systems
At the Africa’s Roadmap to Self-Reliant Healthcare Webinar on August 27, 2025, Dr. Beatrice Matanje, CEO of the National AIDS Commission, delivered a compelling call to action below: The path ahead is not paved with aid but with audacity. Africa has the talent, resolve, and ingenuity to build health systems that serve our people. Let’s...
Post
The Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low-and Middle-Income Countries.
Malawi National AIDS Commissions joins global experts in describing this as a pivotal moment on the road to ending AIDS as a public health threat— ensuring lifesaving innovation reaches those who need it most, wherever they live. The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has announced that it has signed...
Post
HIV Long term injectable drug approved! The National AIDS Commission appeals for continued adherence to present PrEP.
Exciting news! The United States Food and Drug Administration (FDA) has approved an injectable drug for HIV prevention called Lenacapavir (LEN) as Pre-Exposure Prophylaxis. The drug needs to be injected just twice a year for the HIV Negative at-risk population groups. The approval means the drug could be rolled out globally to help overcome barriers...